Evidence map›Paper›PMID 31574981›Full record

ArticleMolecules (Basel, Switzerland)2019

Multi-Evaluating Strategy for Siji-kangbingdu Mixture: Chemical Profiling, Fingerprint Characterization, and Quantitative Analysis.

Zhuoru Yao, Jingao Yu, Zhishu Tang, Hongbo Liu, Kaihua Ruan, Zhongxing Song, Yanru Liu, Kun Yan, Yan Liu, Yuping Tang and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhuoru YaoShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. yaozhuoru0708@gmail.com.
Jingao YuShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. jingao_yu@sina.cn.ORCID 0000-0003-0260-3334
Zhishu TangShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. tzs6565@163.com.
Hongbo LiuShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. 1501010@sntcm.edu.cn.ORCID 0000-0002-7915-9596
Kaihua RuanShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. rkh15709100891@163.com.
Zhongxing SongShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. szx74816@sina.com.
Yanru LiuShaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang 712000, China. 1501011@sntcm.edu.cn.
Kun YanCollege of pharmacy, Shaanxi University of Chinese Medicine, Xixian New Area, Xianyang 712046, China. 18791029030@139.com.
Yan LiuCollege of pharmacy, Shaanxi University of Chinese Medicine, Xixian New Area, Xianyang 712046, China. ly712537@163.com.
Yuping TangCollege of pharmacy, Shaanxi University of Chinese Medicine, Xixian New Area, Xianyang 712046, China. yupingtang9@126.com.
Huqiang MaShaanxi Haitian pharmaceutical co., LTD, Xixian New Area, Xianyang 712046, China. mahuqiang_2016@163.com.

Funding

National Natural Science Foundation of China 81773919 and 81603357Shaanxi Key R&D Program S2020-YF-YBSF-0134Shaanxi Science and Technology Overall Innovation Project 2016KTTSSF01-06-01, 2016KTTSSF02-01, 2018TSCXL-SF-01-01, and 2015KTZDSF02-05-02Shaanxi Special Foundation of technology innovation 2018HJCG-21Special Research Plan of Shaanxi education department 2019-89591065
6 · The paper itself

Abstract

Siji-kangbingdu mixture is an anti-inflammatory, anti-bacterial, and anti-viral herbal mixture which is frequently used by doctors to treat upper respiratory infections. It's important to establish an efficient and economical quality-control method to ensure the quality consistency and efficacy stability of Siji-kangbingdu mixture. In this study, an integrated multi-evaluation method was established, sequentially involving UPLC-TripleTOF-MS analysis, UPLC fingerprint analysis, and the quantitative analysis of multi-components using the single-marker (QAMS) method. With one chromatographic condition, a total of 71 compounds were identified by MS and MS/MS information, with a mass error of less than 5 ppm; 49 peaks detected in 254 nm were selected to establish the fingerprint similarity model, and 7 chemical compounds were simultaneously determined, namely, chlorogenic acid, liquiritin, rutin, isochlorogenic acid A, forsythin, forsythoside A, and glycyrrhizic acid, with forsythoside A as the reference standard. There was no significant difference in the content of the seven compounds between the QAMS method and the external standard method (ESM). The established multi-evaluation method will largely promote the quality control and standardization process of Siji-kangbingdu mixture. It also provides a reference workflow for the overall evaluation of TCM patent medicines, from chemical profiling to fingerprint and quantitative analysis.

Indexed as

Chromatography, High Pressure LiquidCluster AnalysisDrugs, Chinese HerbalLimit of DetectionPhytochemicalsQuality ControlReproducibility of ResultsTandem Mass SpectrometryDrugs, Chinese HerbalPhytochemicalsfingerprintLC-MSQAMSquality evaluationSiji-kangbingdu mixture

Identifiers

PMID31574981
PMCPMC6804210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.